Guangzhou Wondfo Biotech Co.,Ltd.’s Net Profit Rose 110.6% in First Half of 2022

Guangzhou Wondfo Biotech Co.,Ltd. (广州万孚生物技术股份有限公司) (300482.SZ) reported a net profit of 1.2 billion yuan in the first half of 2022, up 110.6% year-on-year.

Meanwhile, the company posted 4 billion yuan in revenue, up 117.3% year-on-year.

At the end of the reporting period, it had 6.4 billion yuan in total assets and 1.8 billion yuan in total liabilities, with a liability-to-asset ratio of 28.4%.